Cargando…

A Novel Four Genes of Prognostic Signature for Uveal Melanoma

Autophagy and immunity play critical roles in various cancers, but the prognostic impact of autophagy and immunity for uveal melanoma (UM) remains lacking. Therefore, the RNA sequencing of data in the TCGA-UVM dataset was downloaded from UCSC Xena database. The prognostic autophagy- and immunity-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yan, Du, Huibin, Wan, Qi, He, Yan, Lu, Wei, Wang, Wenhao, Lv, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005314/
https://www.ncbi.nlm.nih.gov/pubmed/35422861
http://dx.doi.org/10.1155/2022/8281067
_version_ 1784686431554240512
author Liu, Yan
Du, Huibin
Wan, Qi
He, Yan
Lu, Wei
Wang, Wenhao
Lv, Xiaohui
author_facet Liu, Yan
Du, Huibin
Wan, Qi
He, Yan
Lu, Wei
Wang, Wenhao
Lv, Xiaohui
author_sort Liu, Yan
collection PubMed
description Autophagy and immunity play critical roles in various cancers, but the prognostic impact of autophagy and immunity for uveal melanoma (UM) remains lacking. Therefore, the RNA sequencing of data in the TCGA-UVM dataset was downloaded from UCSC Xena database. The prognostic autophagy- and immunity-related genes (AIRGs) were selected via univariate Cox regression. Next, we applied LASSO method to construct four genes of signature in the TCGA-UVM and verified in another two GEO datasets (GSE84976 and GSE22138). This signature intimately associated with overall survival (OS) time and metastasis-free survival (MFS) time of UM, which could be considered as a prognostic indicator. Besides, by applying risk assessment, the patients of UM can be divided into two subgroups (high/low risk) with different survival time, distinct clinical outcomes, and immune microenvironments. Gene set enrichment analysis (GSEA) manifested that cancer hallmark epithelial-mesenchymal transition and KRAS pathways were positively activated in the high-risk group. Moreover, the high-risk group could be more sensitive to chemotherapies than the low-risk group. Thus, our finding suggested that the four genes of signature closely linked with UM risk and survival can afford more accurate survival prediction and potential therapeutic targets for clinical application.
format Online
Article
Text
id pubmed-9005314
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90053142022-04-13 A Novel Four Genes of Prognostic Signature for Uveal Melanoma Liu, Yan Du, Huibin Wan, Qi He, Yan Lu, Wei Wang, Wenhao Lv, Xiaohui J Oncol Research Article Autophagy and immunity play critical roles in various cancers, but the prognostic impact of autophagy and immunity for uveal melanoma (UM) remains lacking. Therefore, the RNA sequencing of data in the TCGA-UVM dataset was downloaded from UCSC Xena database. The prognostic autophagy- and immunity-related genes (AIRGs) were selected via univariate Cox regression. Next, we applied LASSO method to construct four genes of signature in the TCGA-UVM and verified in another two GEO datasets (GSE84976 and GSE22138). This signature intimately associated with overall survival (OS) time and metastasis-free survival (MFS) time of UM, which could be considered as a prognostic indicator. Besides, by applying risk assessment, the patients of UM can be divided into two subgroups (high/low risk) with different survival time, distinct clinical outcomes, and immune microenvironments. Gene set enrichment analysis (GSEA) manifested that cancer hallmark epithelial-mesenchymal transition and KRAS pathways were positively activated in the high-risk group. Moreover, the high-risk group could be more sensitive to chemotherapies than the low-risk group. Thus, our finding suggested that the four genes of signature closely linked with UM risk and survival can afford more accurate survival prediction and potential therapeutic targets for clinical application. Hindawi 2022-04-05 /pmc/articles/PMC9005314/ /pubmed/35422861 http://dx.doi.org/10.1155/2022/8281067 Text en Copyright © 2022 Yan Liu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Yan
Du, Huibin
Wan, Qi
He, Yan
Lu, Wei
Wang, Wenhao
Lv, Xiaohui
A Novel Four Genes of Prognostic Signature for Uveal Melanoma
title A Novel Four Genes of Prognostic Signature for Uveal Melanoma
title_full A Novel Four Genes of Prognostic Signature for Uveal Melanoma
title_fullStr A Novel Four Genes of Prognostic Signature for Uveal Melanoma
title_full_unstemmed A Novel Four Genes of Prognostic Signature for Uveal Melanoma
title_short A Novel Four Genes of Prognostic Signature for Uveal Melanoma
title_sort novel four genes of prognostic signature for uveal melanoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005314/
https://www.ncbi.nlm.nih.gov/pubmed/35422861
http://dx.doi.org/10.1155/2022/8281067
work_keys_str_mv AT liuyan anovelfourgenesofprognosticsignatureforuvealmelanoma
AT duhuibin anovelfourgenesofprognosticsignatureforuvealmelanoma
AT wanqi anovelfourgenesofprognosticsignatureforuvealmelanoma
AT heyan anovelfourgenesofprognosticsignatureforuvealmelanoma
AT luwei anovelfourgenesofprognosticsignatureforuvealmelanoma
AT wangwenhao anovelfourgenesofprognosticsignatureforuvealmelanoma
AT lvxiaohui anovelfourgenesofprognosticsignatureforuvealmelanoma
AT liuyan novelfourgenesofprognosticsignatureforuvealmelanoma
AT duhuibin novelfourgenesofprognosticsignatureforuvealmelanoma
AT wanqi novelfourgenesofprognosticsignatureforuvealmelanoma
AT heyan novelfourgenesofprognosticsignatureforuvealmelanoma
AT luwei novelfourgenesofprognosticsignatureforuvealmelanoma
AT wangwenhao novelfourgenesofprognosticsignatureforuvealmelanoma
AT lvxiaohui novelfourgenesofprognosticsignatureforuvealmelanoma